Help your patient take the next step toward relief.
Refer someone in your care or community for Spravato® treatment — the only FDA-approved option for people with treatment-resistant depression.
For patients who are stuck.
Spravato® may be an option for adults with depression who:
Have tried two or more antidepressants without adequate relief
Are experiencing depression with suicidal thoughts or actions and are clinically appropriate for treatment
Are already in therapy and could benefit from medical treatment alongside their therapeutic care
Are looking for another option after repeated antidepressant trials haven't provided sufficient relief
~14%
achieve remission after a third line of standard antidepressant treatment
52.5%
achieved remission at Day 28 with Spravato® + an oral antidepressant in a pivotal Phase 3 trial
What to Expect
Every session is administered and monitored by a Spravato®-trained clinician for your safety.
Click here to learn more about Spravato®.
Why Journey Clinical?
Our medical team manages every aspect of your patient's Spravato® treatment, from determining eligibility and prescribing to ongoing monitoring and clinical support. Their existing providers remain an important part of their care, so adding Spravato® doesn't mean disrupting the relationships they already trust.
Unlike other clinics, Spravato® sessions with Journey Clinical take place in a therapist's private office—not a large clinic or hospital setting. Patients receive treatment alongside just a few others in a calm, quiet environment designed to support their experience rather than distract from it.
.webp)
Every patient you refer receives physician-supervised care grounded in clinical expertise, thoughtful oversight, and compassion. Our goal is to work together to deliver care that is safe, coordinated, and centered on each patient's well-being.
Questions?
Email us at spravato@journey.clinic or call 914-306-5174.